Fig. 5 Clustering of the distal gut microbiome, the C

Slides:



Advertisements
Similar presentations
Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity by Alice P. Liou, Melissa Paziuk, Jesus-Mario Luevano, Sriram.
Advertisements

The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice by Peter J. Turnbaugh, Vanessa K. Ridaura, Jeremiah.
Fig. 4 Bacterial taxonomic groups that discriminate among RYGB-, SHAM-, and WMS-derived samples. Bacterial taxonomic groups that discriminate among RYGB-,
Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.
Fig. 1. Identification of SE-associated lncRNAs.
Correlation of mouse gene expression with bacterial gene expression.
Splenic CD169+ macrophages express a unique gene profile.
Tfr cells’ transcriptomic profile distinguishes them from Treg and Tfh cells. Tfr cells’ transcriptomic profile distinguishes them from Treg and Tfh cells.
Decreased weight and adiposity is transmissible via the gut microbiota
Fig. 1 Schematic of experimental design.
Fig. 5 Early and modest immune response at day 3 after exposure in Delayed animals. Early and modest immune response at day 3 after exposure in Delayed.
Human cells produce type I and III IFNs upon Af stimulation.
Fig. 2. CD treatment facilitates regression of murine atherosclerosis.
Differential expression of TRM markers by donor- and recipient-derived T cells with time. Differential expression of TRM markers by donor- and recipient-derived.
Fig. 6 Transmissibility of adiposity from humanized mice to germ-free recipients. Transmissibility of adiposity from humanized mice to germ-free recipients.
Fig. 7 Correlation of NHP and human ISGs.
Fig. 4. Peanut-specific TH2A cells are specifically targeted during immunotherapy. Peanut-specific TH2A cells are specifically targeted during immunotherapy.
Biocompatibility evaluation in vivo with a mouse subcutaneous implant
Microbial communities of the differently treated mice with lupus cluster separately after treatment. Microbial communities of the differently treated mice.
Fig. 1. Generation of the ΔEx50 mouse model.
Fig. 3. The effect of VRC01 infusion on virus load in plasma and blood CD4 T cells during ART. The effect of VRC01 infusion on virus load in plasma and.
Consolidated Standards of Reporting Trials flow diagram of VRC trial
Fig. 1. Loss of circadian rhythms in iKO mice.
Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.
Fig. 5. Microarray analysis of tumors treated by dabrafenib, trametinib, or the combination of dabrafenib and trametinib with pmel-1 ACT or mock ACT. Microarray.
Fig. 1. Schematic showing the shedding of tumor DNA from head and neck cancers into the saliva or plasma. Schematic showing the shedding of tumor DNA from.
Fig. 6. TIV-09, but not MIV-09, induces an IFN signature in the blood of vaccinated individuals at day 1. TIV-09, but not MIV-09, induces an IFN signature.
Fig. 4. The effect of combined inhibition of BCL-2 and BCR-ABL on leukemia LT-HSC frequency. The effect of combined inhibition of BCL-2 and BCR-ABL on.
mtDNA genotypes correlate with gut microbiota composition.
CD4+CLA+CD103+ T cells from human blood and skin share a transcriptional profile. CD4+CLA+CD103+ T cells from human blood and skin share a transcriptional.
The ND6P25L mtDNA mutation reduces gut microbiota diversity in C57BL/6J mice. The ND6P25L mtDNA mutation reduces gut microbiota diversity in C57BL/6J mice.
Fig. 2. Deficiency of neuronal HS leads to reduced neuroinflammation.
Fig. 2. Bacterial/viral score in COCONUT-conormalized whole-blood validation data sets. Bacterial/viral score in COCONUT-conormalized whole-blood validation.
Fig. 5. Col IV–Ac2-26 NPs decrease lesion area, necrotic area, and oxidative stress in brachiocephalic arterial plaques. Col IV–Ac2-26 NPs decrease lesion.
Colonization in tumor models and different modes of administration
Fig. 5. Vitamin B12 supplementation in the host altered the transcriptome of P. acnes in the skin microbiota. Vitamin B12 supplementation in the host altered.
Fig. 5 Transcriptional changes in dKO mice after HFD regimen.
Fig. 1. Potent and selective down-regulation of KRAS mRNA and protein by AZD4785 in vitro and in vivo. Potent and selective down-regulation of KRAS mRNA.
Fig. 1 Inbred mouse strains carrying monoclonal tumors display a symmetrical yet disparate response to ICB, associated with a distinctive gene signature.
Fig. 7 BMS reduces the elevated expression of type I IFN–regulated genes both ex vivo in blood from patients with lupus and in a phase 1 study of.
BMS blocks functional responses in primary immune cells driven by IFNα
Drug response profiles and experimental validation.
Fig. 1. Detection of circulating tumor DNA in CRPC patients.
by Peter J. Turnbaugh, Vanessa K. Ridaura, Jeremiah J
The microchip-based drug delivery device and overview of study design
Fig. 4 Control analyses ensured that the relation between rotational acceleration and changes in FA does not depend on thresholds. Control analyses ensured.
Fig. 3 Transcriptional changes in dKO mice.
Fig. 4. Paclitaxel promotes the expression of invasive isoforms of MENA in the primary breast cancer microenvironment. Paclitaxel promotes the expression.
by Dezhi Kang, Baochen Shi, Marie C. Erfe, Noah Craft, and Huiying Li
Fig. 1. CCR5-TALEN and CCR5-megaTAL activity in T cells and comparison of NHEJ and HDR events in a TLR reporter line. CCR5-TALEN and CCR5-megaTAL activity.
LTB4 production is elevated in preclinical and clinical lymphedema
Fig. 4 Effects of hematopoietic restoration of TLR9 on adipose tissue inflammation and insulin resistance. Effects of hematopoietic restoration of TLR9.
Fig. 8. Purkinje cell quantification and hearing threshold in NPC cats administered IC HPβCD. Purkinje cell quantification and hearing threshold in NPC.
Tregs preferentially regulate TH2 cytokines in skin.
Fig. 1 Intra-amniotic delivery of CRISPR-Cas9 results in pulmonary gene editing. Intra-amniotic delivery of CRISPR-Cas9 results in pulmonary gene editing.
miR can promote cardiomyocyte proliferation in the adult heart
Fig. 1. Dysbiosis of the skin microbiome in AD is associated with S
Fig. 1 ZMAb improves survival of EBOV-challenged NHPs
Fig. 3. miR overexpression leads to increased cell proliferation as well as altered differentiation and metabolism in cardiomyocytes. miR
Fig. 2. Mechanism of PD-L1 down-regulation in NOD HSPCs.
Fig. 2. Col IV–Ac2-26 NPs increase subendothelial collagen in Ldlr−/− mice with established atherosclerosis. Col IV–Ac2-26 NPs increase subendothelial.
Fig. 3. Association between peak CTL019 expansion and response.
Fig. 3. Col IV–Ac2-26 NPs suppress lesional superoxide and increase lesional Il10 mRNA in Ldlr−/− mice with established atherosclerosis. Col IV–Ac2-26.
Fig. 1. Schematic description of whole-exome or targeted next-generation sequencing analyses. Schematic description of whole-exome or targeted next-generation.
Fig. 1 Generation and characterization of MeV-based vaccine candidates for Lassa virus. Generation and characterization of MeV-based vaccine candidates.
Fig. 8 Immune correlates of protection.
Fig. 3 Postnatal assembly of the humanized gut microbiota.
Fig. 2 Combined transcriptome profiling, ChIP-seq, and ATAC-seq analysis identifies 14 highly plausible direct targets of Runx. Combined transcriptome.
Fig. 3. Effects of SFN in mice with diet-induced diabetes.
Fig. 2 Astrocyte-specific AAV2/5 RiboTag.
Presentation transcript:

Fig. 5 Clustering of the distal gut microbiome, the C Fig. 5 Clustering of the distal gut microbiome, the C. innocuum SB23 transcriptome, and the community meta transcriptome in the ceca of humanized mice. Clustering of the distal gut microbiome, the C. innocuum SB23 transcriptome, and the community meta transcriptome in the ceca of humanized mice. Microbiome or transcriptome profiles were normalized by z score, used to construct a correlation distance matrix, clustered with UPGMA (unweighted pair group method with arithmetic mean), and visualized (see Supplementary Material; Matlab version 7.7.0). (A) Clustering of fecal microbial gene content in the human donor’s microbiome and two groups of humanized mice starting at day 1 after colonization (n = 3 to 5 mice per group; fecal DNA was pooled before sequencing). All mice were maintained on the LF/PP diet (red) for 28 days, at which point group 2 was transferred to the Western diet (blue). (B) Clustering of C. innocuum SB23 gene expression in humanized mice fed the LF/PP (red) or Western (blue) diet. (C) Clustering of the gut microbiome’s meta transcriptome in humanized mice fed a LF/PP (red) or a Western (blue) diet. Black circles represent validated clusters (inconsistency threshold = 0.75, “cluster” function in Matlab version 7.7.0). (D) qRT-PCR validation of C. innocuum SB23 gene expression in humanized mice (n = 3 to 5 samples per group; see Supplementary Material). Mean values ± SEM are plotted (*P < 0.05, Student’s t test). Peter J. Turnbaugh et al., Sci Transl Med 2009;1:6ra14 Copyright © 2009, American Association for the Advancement of Science